- Home
- NX vs AVDL Comparison
NX vs AVDL Comparison
Compare NX & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NX
- AVDL
- Stock Information
- Founded
- NX 1927
- AVDL 2015
- Country
- NX United States
- AVDL Ireland
- Employees
- NX N/A
- AVDL N/A
- Industry
- NX Metal Fabrications
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- NX Industrials
- AVDL Health Care
- Exchange
- NX Nasdaq
- AVDL Nasdaq
- Market Cap
- NX 1.1B
- AVDL 786.3M
- IPO Year
- NX N/A
- AVDL 1996
- Fundamental
- Price
- NX $19.96
- AVDL $8.02
- Analyst Decision
- NX Strong Buy
- AVDL Strong Buy
- Analyst Count
- NX 1
- AVDL 6
- Target Price
- NX $38.00
- AVDL $20.00
- AVG Volume (30 Days)
- NX 361.7K
- AVDL 1.8M
- Earning Date
- NX 03-06-2025
- AVDL 03-03-2025
- Dividend Yield
- NX 1.60%
- AVDL N/A
- EPS Growth
- NX N/A
- AVDL N/A
- EPS
- NX 0.90
- AVDL N/A
- Revenue
- NX $1,277,862,000.00
- AVDL $138,160,000.00
- Revenue This Year
- NX $50.17
- AVDL $515.63
- Revenue Next Year
- NX $2.87
- AVDL $49.32
- P/E Ratio
- NX $22.21
- AVDL N/A
- Revenue Growth
- NX 13.03
- AVDL 1523.50
- 52 Week Low
- NX $19.57
- AVDL $7.39
- 52 Week High
- NX $39.31
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- NX 24.82
- AVDL 35.71
- Support Level
- NX $22.62
- AVDL $7.40
- Resistance Level
- NX $24.79
- AVDL $8.07
- Average True Range (ATR)
- NX 0.70
- AVDL 0.35
- MACD
- NX -0.18
- AVDL 0.08
- Stochastic Oscillator
- NX 7.47
- AVDL 34.33
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its three operating segments are North American Fenestration being the key revenue driver, European Fenestration, and North American Cabinet Components. Geographically, it derives a majority of revenue from the United States.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.